Medical technology company OsteoCentric Technologies announced on Tuesday that it has entered a non-exclusive licensing agreement with Globus Medical, Inc.

This innovative technology advances the orthopaedic industry beyond traditional interfaces that can harm bone during implant insertion. OsteoCentric's MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form offers a unique implant-to-bone interface that ensures sustained primary implant stability.

OsteoCentric Technologies aims to drive adoption of its technology across multiple orthopaedic market segments, including Total Joint Reconstruction, Trauma, Spine, SI Joint Fusion, Sports Medicine, Extremities, Veterinary, Oncology, Bone Anchored Prostheses and Dental applications.